MedTrace Logo

Effect of Selenium Supplementation on Influenza Vaccination

NCT04188483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-02-17

No results posted yet for this study

Summary

The study is designed to assess whether selenium supplementation can boost the immunity response to influenza vaccination in healthy adults. This is a randomized, prospective study enrolling a total of 60 healthy subjects, 18-55 years old.

Conditions

  • Selenium Supplementation
  • Influenza Vaccination

Interventions

DIETARY_SUPPLEMENT

Selenium Supplementation

The selenium supplementation group will receive 200 μg selenium daily by taking two selenium-enriched yeast tablets (SelenoPrecise®, Pharma Nord) once daily for 60 days.

BIOLOGICAL

Influenza vaccination

Subjects will receive standard seasonal influenza vaccination for the 2019-2020 season.

Sponsors & Collaborators

  • The University of Queensland

    collaborator OTHER

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Zheng Liu, Doctor · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2019-12-31
Completion
2020-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04188483 on ClinicalTrials.gov